NSC |
Compound |
Enrichment |
Correlation |
NSC 693547 |
2-Amino-4-(2-hydroxy-4-methylphenyl)-5-phenylpyrimidine |
0.00662388971299138 |
0.36202809 |
NSC 694269 |
Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate |
0.00662388971299138 |
0.44352751 |
NSC 697194 |
Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- |
0.00662388971299138 |
0.38575598 |
NSC 724448 |
Null |
0.00662388971299138 |
0.26664493 |
NSC 724955 |
6-Ethylmercapto-4-(2'-thienylidine amino)pyrazolo[3,4-d]pyrimidine |
0.00662388971299138 |
-0.11571321 |
NSC 727048 |
11-(3'-Methylaminopropylidene]-5,6-dihydro-5-keto-2,3-dimeth oxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinolin e |
0.00662388971299138 |
0.48398609 |
NSC 734307 |
3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide |
0.00662388971299138 |
0.35933562 |
NSC 407809 |
Card-20(22)-enolide, 3-[(6-O-.beta.-D-glucopyranosyl-.beta.-D-glucopyranosyl)oxy]-14-hydroxy-, (3.beta.,5.alpha.)- (9CI) |
0.00663743932906076 |
0.23928902 |
NSC 174121 |
Methotrexate Derivative |
0.00744479268267742 |
0.70665718 |
NSC 647638 |
1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) |
0.00744479268267742 |
-0.0087050852 |